Education
About Us
Working with TipRanks
Follow Us
Innoveren Scientific (IVRN)
OTHER OTC:IVRN
IVRN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.03 - $0.03
Previous CloseN/A
Volume59.00
Average Volume (3M)0.00
Market Cap
$649.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta563.61
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.75
Shares Outstanding3,244,008
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Innoveren Scientific News
PremiumCompany Announcements
Innoveren Scientific Unveils Future-Shaping Development Update
PremiumCompany Announcements
Innoveren Scientific Enhances Finances with Strategic Equity SaleOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
― Other Institutional Investors
100.00% Public Companies and
Individual Investors
IVRN FAQ
What was Innoveren Scientific’s price range in the past 12 months?
Innoveren Scientific lowest stock price was $0.03 and its highest was $0.03 in the past 12 months.
What is Innoveren Scientific’s market cap?
Innoveren Scientific’s market cap is $649.00.
When is Innoveren Scientific’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Innoveren Scientific’s earnings last quarter?
Innoveren Scientific released its earnings results on May 11, 2018. The company reported -$0.06 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.06.
Is Innoveren Scientific overvalued?
According to Wall Street analysts Innoveren Scientific’s price is currently Overvalued.
Does Innoveren Scientific pay dividends?
Innoveren Scientific does not currently pay dividends.
What is Innoveren Scientific’s EPS estimate?
Innoveren Scientific’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Innoveren Scientific have?
Innoveren Scientific has 3,244,008 shares outstanding.
What happened to Innoveren Scientific’s price movement after its last earnings report?
Innoveren Scientific reported an EPS of -$0.06 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Innoveren Scientific?
Currently, no hedge funds are holding shares in IVRN
Company Description
Innoveren Scientific
H-Cyte, Inc. engages in the design and marketing of proprietary medical devices for commercial use in the United States and Europe. It offers DenerveX device, which provides pain relief from facet joint syndrome. The company was founded by Scott M. W. Haufe and Steven Gorlin on July 30, 2013 and is headquartered in Tampa, FL.
Biodexa Pharmaceuticals
―
Salarius Pharmaceuticals
―
Processa Pharmaceuticals
―
GRI Bio
―
Onconetix
―